MCLA-145

· Merus B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MCLA-145, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies [Phase 1]